...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >The effect of hospitalization on oral anticoagulation control: a population-based study.
【24h】

The effect of hospitalization on oral anticoagulation control: a population-based study.

机译:住院对口服抗凝治疗的影响:一项基于人群的研究。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: For patients taking oral anticoagulants (OAC), the proportion of time spent in the therapeutic range is strongly associated with bleeding and thromboembolic risk. Previous studies examining OAC control may not generalize because the patient population was select or INR capture was incomplete. OBJECTIVES: Measure OAC control for an entire population of elderly people and determine patient factors associated with OAC control. PATIENTS: People in Eastern Ontario without valve replacement aged 65 years or greater who were treated with warfarin between 1 September 1999 and 1 September 2000. DESIGN: Retrospective cohort study using population-based administrative databases. OAC control was measured as the proportion of days in therapeutic range (PDTR), defined as the number days with the INR between 2 and 3 divided by total number of days observation. Linear interpolation was used to determine INR levels between measures. Negative binomial regression was used to identify patient factors independently associated with PDTR. We also determined which factors were associated with proportion of days with a critically low (<1.5) or critically high (>/=5) INR. RESULTS: 7179 people were followed for a total of 3238 years. 15% of people were hospitalized during the study. Overall, PDTR was 59.2% (95% CI 59.1%-59.2%). Independent of all other significant factors, hospitalization was associated with a 15% decrease in the PDTR 15% (rate ratio 0.85, 95% CI 0.83-0.87). Hospitalization was also independently associated with greater proportion of time with a critically low INR (rate ratio 1.68, 95% CI 1.51-1.88) and a critically high INR (1.70, 95% CI 1.38-2.08). CONCLUSIONS: Elderly people in eastern Ontario taking warfarin were therapeutic 59.2% of the time. Independent of other patient factors, patients who are hospitalized have the greatest risk of poor anticoagulation control. Control for anticoagulated patients who get hospitalized should be reviewed to determine if and how it could be improved.
机译:背景:对于服用口服抗凝剂(OAC)的患者,在治疗范围内花费的时间比例与出血和血栓栓塞风险密切相关。以前检查OAC控制的研究可能没有推广,因为选择了患者人群或INR捕获不完全。目的:测量整个老年人群的OAC控制,并确定与OAC控制相关的患者因素。患者:1999年9月1日至2000年9月1日期间接受华法林治疗的年龄在65岁以上的安大略省东部无瓣膜置换的患者。设计:使用基于人群的管理数据库进行的回顾性队列研究。将OAC对照衡量为治疗范围内的天数比例(PDTR),定义为INR在2到3之间的天数除以观察到的总天数。线性插值用于确定度量之间的INR水平。负二项式回归用于确定独立于PDTR的患者因素。我们还确定了哪些因素与INR严重低(<1.5)或临界高(> / = 5)的天数比例有关。结果:7179人被随访了3238年。研究期间有15%的人住院。总体而言,PDTR为59.2%(95%CI 59.1%-59.2%)。与所有其他重要因素无关,住院与PDTR降低15%(15%)有关(比率0.85,95%CI 0.83-0.87)。住院时间也与更长的时间比例相关,其中INR极低(比率比率1.68,95%CI 1.51-1.88)和INR极高(1.70,95%CI 1.38-2.08)。结论:安大略省东部的老年人服用华法林治疗的时间为59.2%。与其他患者因素无关,住院患者抗凝控制不良的风险最大。应对住院抗凝治疗的患者进行对照检查,以确定是否以及如何加以改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号